Kiara Fairman Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
Kiara Fairman's research focuses on the application of physiologically based pharmacokinetic (PBPK) modeling across various scientific domains. Her work investigates the utility of New Approach Methodologies (NAMs) for chemical risk assessments, particularly in life stage-specific contexts. Fairman also explores computational models for predicting physicochemical and pharmacokinetic properties of botanical constituents. Her publications address the application of PBPK modeling in forensic science and its use in estimating drug metabolism and ADME processes in specific populations, including pregnant individuals and infants. She has co-authored research on maternal and maternal-fetal PBPK models for assessing therapeutic efficacy and safety during pregnancy, and on predicting drug exposure in breast milk. Fairman's collaborations include work with Pavani Gonnabathula, Me-Kyoung Choi, and Miao Li, all affiliated with the National Center for Toxicological Research.
Metrics
- h-index: 7
- Publications: 15
- Citations: 89
Selected Publications
-
Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters (2025)
-
Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations (2025)
-
Application of Lactation Physiologically Based Pharmacokinetic Modeling to Predict Milk Exposure of Passively Diffused Drugs (2025)
-
S20-02 Maternal and maternal-fetal PBPK models for estimating therapeutic efficacy and safety in pregnancy (2024)
-
Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs) (2024)
-
Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models (2024)
-
An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science (2023)
-
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges (2021)
Collaboration Network
Top Collaborators
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
- Featured Cover
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
- Featured Cover
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
- Featured Cover
- Prediction of physicochemical and pharmacokinetic properties of botanical constituents by computational models
- Featured Cover
- Applications of PBPK Modeling to Estimate Drug Metabolism and Related ADME Processes in Specific Populations
- Physiologically based pharmacokinetic modeling of oseltamivir in pregnant rhesus macaques to inform clinical dosing across trimesters
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
- Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- An Overview of Physiologically-Based Pharmacokinetic Models for Forensic Science
- Utility of life stage-specific chemical risk assessments based on New Approach Methodologies (NAMs)
Similar Researchers
Based on overlapping research topics